Clinical Trial Update: proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a sodium-glucose cotransporter 2 (SGLT-2) inhibitor for renoprotection in patients undergoing cardiac surgery; status is activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• SGLT-2 inhibitor

Snippet

Sponsor: Amsterdam UMC | Conditions: Acute Kidney Injury, Cardiac Surgery | Phase 4 | Status: ACTIVE_NOT_RECRUITING